Circulars 544 and 545 concerning the person responsible for pharmacovigilance

Any holder of Belgian marketing authorisation (MA) or registration of medicines for human or veterinary use must notify the Federal Agency for Medicines and Health Products (FAMHP) the name of the person responsible for pharmacovigilance. Circulars 544 and 545 are a reminder of that obligation and provide practical information about it.

See other languages (French or Dutch)

Circular 544

Circular 545

 

 

 

 

 

 

 

 

 

 

 

 

Last updated on
01/12/2009